Liver Cancer: Why Early Diagnosis Saves Lives

Liver cancer is one of the fastest-rising causes of cancer-related death in the UK. Yet many people remain unaware that they are even at risk.

Unlike breast, bowel or cervical cancer, there is no national screening programme for liver cancer among the general UK population. Consequently, the vast majority of cases are not diagnosed until the disease has reached an advanced stage. Only around 13–15% of people in the UK survive five years or more after a liver cancer diagnosis — largely because it is picked up far too late.

What Is Liver Cancer?

Primary liver cancer most commonly develops as a result of long-term, underlying liver damage. Typical causes include:

• Alcohol-related liver disease (ARLD)
• Chronic Hepatitis B or Hepatitis C infections
• Non-Alcoholic Fatty Liver Disease (NAFLD / NASH)
• Cirrhosis (scarring of the liver)
• Type 2 diabetes and obesity

Recognising the Symptoms

• Unexplained weight loss persisting for over a month
• Loss of appetite or feeling full quickly
• Persistent tiredness that does not improve with rest
• Upper abdominal discomfort, often on the right side
• Jaundice — yellowing of the skin or eyes

Is There a Screening Programme?

There is no routine NHS screening for the general public, but high-risk individuals — those with cirrhosis or chronic hepatitis — are offered surveillance every six months, typically with liver function blood tests, AFP biomarkers and abdominal ultrasound.

How Is It Diagnosed?

If liver cancer is suspected, your GP will arrange baseline blood tests and an urgent abdominal ultrasound. If abnormalities are found, a hepatobiliary specialist will use CT, MRI and a multi-disciplinary team (MDT) assessment to confirm the diagnosis and design a personalised treatment plan.

Why Early Diagnosis Matters

Stage 1 disease offers around a 50% four-year survival rate with curative options (surgical resection, ablation or liver transplant). Stage 4 disease has a roughly 5% four-year survival and is focused on systemic and symptom-control treatment. Catching it early is the single biggest factor in outcome.